Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium acetate anhydrous + calcium chloride + magnesium chloride + potassium chloride + sodium chloride
- Development stage
- Unknown
- Lead developer
- Pfizer
- Modality
- Small Molecules
- Administration
- Intravenous, Parenteral
01
Overview
TPN Electrolytes is a sterile multi-electrolyte **small-molecule inorganic salt combination** containing sodium acetate anhydrous, calcium chloride, magnesium chloride, potassium chloride, and sodium chloride for intravenous administration **only after dilution and thorough mixing** in parenteral nutrition solutions. Developed and marketed by Hospira and associated with Pfizer, it is used as an electrolyte additive to concentrated dextrose and amino acid solutions administered by central venous infusion to maintain or restore electrolyte homeostasis in adults receiving total parenteral nutrition. Its mechanism is direct physiologic replacement of essential electrolyte ions including sodium, potassium, calcium, magnesium, chloride, and acetate, thereby supporting normal membrane potentials, neuromuscular function, fluid balance, and acid-base buffering rather than acting through a single discrete molecular target.
- Brand names
- TPN Electrolytes
- Other names
- multiple electrolyte additiveparenteral electrolyte supplementsodium acetate anhydrous + calcium chloride + magnesium chloride + potassium chloride + sodium chloride
Beyond the preview
Go deeper on sodium acetate anhydrous + calcium chloride + magnesium chloride + potassium chloride + sodium chloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium acetate anhydrous + calcium chloride + magnesium chloride + potassium chloride + sodium chloride.